Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT1308 plus platinum-based chemotherapy for first-line treatment of advanced or recurrent dMMR endometrial cancer
CTR20240036Phase 2Terminated
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Jan 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of BAT1308 in endometrial cancer (EC), sponsored by Bio-Thera Solutions, Ltd.. Started Jan 2024; status: terminated.
02
Drugs
BAT1308
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on CTR20240036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240036.